Read the First Edition of The Lens, a new magazine by LSI
Learn More About Neuraltus Pharmaceuticals
Neuraltus Pharmaceuticals
image
High-impact therapeutics that address critical unmet needs, primarily in the treatment of neurodegenerative diseases such as: Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig\'s disease), Parkinson\'s disease, Alzheimer\'s disease (AD), and multiple sclerosis (MS), as well as lysosomal storage disorders such as Fabry\'s disease and Gaucher\'s disease
Technology/product details
Revenue projections
Capital raised to date
Growth strategy
Competing Startups
More

Get a Demo and See the Full Profile

Get a demo today to see profiles of Spineology plus 6164 other startups.

Trusted By The Companies Pioneering What’s Next